CClinicalTrials.gg
RecruitingNCT06361225Updated May 11, 2025

Routine Use of RUSH Protocol in the Intensive Care Unit

An observational study in RUSH Protocol, sponsored by Meir Medical Center. Recruiting at 1 site in Israel. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2025-05-11.

Sponsored by Meir Medical Center · Observational

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 2 months ago, but the record still lists the study as recruiting.
  • Started Dec 2024; still recruiting 1 year 10 months later.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
50
Ages
18 Years to 99 Years
Sex
All
01

Study summary

The RUSH protocol has been used for several years for the rapid evaluation of a patient admitted to the emergency room with shock. Traditionally, its use was especially common in trauma victims, but later its use was extended to patients admitted to the emergency room with shock from any reason. The protocol includes rapid assessment with the guideness of ultrasound of heart contraction, assessment for pleural effusions, assessment of intra-abdominal blood (FAST), diagnosis of venous thrombosis (DVT), and rulling out hydronephrosis. It can also add a pupil size assessment and an evaluation of the gallbladder and bile ducts, as well as the size of the bladder. In intensive care, we use this protocol (or part of it) for the evaluation of a patient who is deteriorating in the ICU for an unknown reason . In some patients we use this protocol as a routine part of the physical examination as part of the daily patient evaluation.

We would like to investigate whether the routine use of the RUSH protocol as part of the daily patient evaluation in the general intensive care unit will lead to any change in the patient's management.

02

Conditions studied

  • RUSH Protocol
03

In context

Lead sponsor

Meir Medical Center is the lead sponsor of 389 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who were admitted to the intensive care unit for any reason and were evaluated daily using the RUSH protocol.

Eligibility criteria

Inclusion Criteria:

  • Patients who were admitted to the intensive care unit for any reason and were evaluated daily using the RUSH protocol.

Exclusion Criteria:Patients who were not evaluated using the RUSH protocol or for whom data were missing.

-

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No

Interventions

  • Diagnostic testevaluation with RUSH protocol

    Daily evaluation of the patient via ultrasound using the RUSH protocol

06

What researchers measure

Primary outcomes

  1. Change of patient medical therapy

    Adding a new medical therapy= yes/no (1/0), changing the dose of an existing medical therapy (increase/decrease=1/0)

    Time frame: from day 0 to day 3 of performing the RUSH protocol

  2. Performing unplanned laboratory tests

    Performing unplanned laboratory tests as a result of the RUSH protocol- yes/no (=1/0)

    Time frame: from day 0 to day 3 of performing the RUSH protocol

  3. Performing unplanned image tests

    Performing unplanned image tests (CXR, CT etc.) as a result of the RUSH protocol- yes/no (=1/0)

    Time frame: from day 0 to day 3 of performing the RUSH protocol

  4. Performing unplanned invasive procedure

    Performing unplanned invasive procedure (surgery, minimally invasive procedure)- yes/no (1/0)

    Time frame: from day 0 to day 3 of performing the RUSH protocol

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06361225
Lead sponsor
Meir Medical Center
Responsible party
sara dichtwald (Dr, Meir Medical Center) — Principal investigator
First posted
Apr 11, 2024
Start date
Dec 1, 2024
Primary completion
Aug 1, 2025 (estimated)
Completion
Aug 1, 2025 (estimated)
Last update
May 11, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion